Shanghai Junshi Biomedical Technology Co., Ltd
Shanghai Junshi Biomedical Technology Co., Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer | Pancreatic Cancer Metastatic | Recruiting | Phase 1 / Phase 2 | 2026-05-18 | NCT07040228 |